F-H Remedy wins Takeda Euro job

Japanese pharma firm ­Takeda is to use Fleishman-Hillard's London medical education arm The Remedy to run its pan-European medical meetings in 2007.

The agency has been retained by Takeda for the past two years but was nonetheless made to repitch against three undisclosed agencies to secure a contract extension for 2007 estimated to be worth around £750,000.

The new contract will continue The Remedy's work on medical meetings to support Actos (pioglitzone), Blopress (candesartan) and leuprorelin, but includes meetings for pre-launch insomnia drug ramelteon.

Projects on other drugs in Takeda's research pipeline are also being considered.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in